Repare Therapeutics Inc. Common Shares
RPTX US7602731025
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
Person | Price | Shares | Total | Published | Completed |
---|---|---|---|---|---|
Forte Steve EX VP |
1.14 USD |
6,884 Sold |
7,848 USD |
12/03/2025 | 12/03/2025 |
Koehler Maria CMO |
1.14 USD |
3,596 Sold |
4,099 USD |
12/03/2025 | 12/03/2025 |
Koehler Maria CMO |
4.66 USD |
300 Sold |
1,398 USD |
28/03/2024 | 01/04/2024 |
Segal Lloyd Mitchell CEO |
4.63 USD |
2,491 Sold |
11,533 USD |
28/03/2024 | 01/04/2024 |
Zinda Michael EX VP |
4.66 USD |
410 Sold |
1,911 USD |
28/03/2024 | 01/04/2024 |
Forte Steve EX VP |
4.61 USD |
789 Sold |
3,637 USD |
28/03/2024 | 01/04/2024 |
Forte Steve EX VP |
4.62 USD |
825 Sold |
3,812 USD |
28/03/2024 | 28/03/2024 |
Koehler Maria CMO |
4.64 USD |
500 Sold |
2,320 USD |
28/03/2024 | 28/03/2024 |
Zinda Michael EX VP |
4.64 USD |
450 Sold |
2,088 USD |
28/03/2024 | 28/03/2024 |
Segal Lloyd Mitchell CEO |
4.62 USD |
2,650 Sold |
12,243 USD |
28/03/2024 | 28/03/2024 |